OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis
Fang‐tian Bu, Yan Zhu, Xin Chen, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 847-862
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases
Xianhui Zeng, Xianglei Yuan, Qiuyu Cai, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1945-1945
Open Access | Times Cited: 47

Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease
Yuru Zong, Xuliang Wang, Bing Cui, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1562-1576
Open Access | Times Cited: 22

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
Runping Liu, Yajing Li, Qi Zheng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1009-1029
Open Access | Times Cited: 20

Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update
Yu Zheng, Long Xie, Dejun Yang, et al.
Phytomedicine (2023) Vol. 113, pp. 154721-154721
Closed Access | Times Cited: 18

N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation
Xin Chen, Sai Zhu, Hai-Di Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125811-125811
Closed Access | Times Cited: 18

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40

hnRNPL-activated circANKRD42 back-splicing and circANKRD42-mediated crosstalk of mechanical stiffness and biochemical signal in lung fibrosis
Pan Xu, Jinjin Zhang, Meirong Wang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2370-2387
Open Access | Times Cited: 26

Proangiogenic role of circRNA ‐007371 in liver fibrosis
Chong Zhao, Shuaijie Qian, Yang Tai, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 14

CircRNAs: versatile players and new targets in organ fibrosis
Lei Wei, Limin Liu, Ming Bai, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11

circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma
Liangliang Xu, Peng Wang, Li Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11

BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
Chuang Li, Xiaojuan Zhao, Jingge Zhao, et al.
BMC Molecular and Cell Biology (2025) Vol. 26, Iss. 1
Open Access

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis
Kurt Sartorius, Ying Wang, Benn Sartorius, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases
Cheng Wang, Honglin Zhou, Rui Wu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114040-114040
Open Access | Times Cited: 16

Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
Guocheng Rao, Peng Xi, Yan Tian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
Archittapon Nokkeaw, Pannathon Thamjamrassri, Pisit Tangkijvanich, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 378-378
Open Access | Times Cited: 8

Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
MÉLISSA YEPMO, Jean-Baptiste Potier, M. Pinget, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11

Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis
Gaiping Wang, Jiahui Tong, Y.-C. Li, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 940-940
Open Access | Times Cited: 6

Myc-mediated circular RNA circMcph1/miR-370-3p/Irak2 axis is a progressive regulator in hepatic fibrosis
Jinjin Xu, Xin Chen, Sai Zhu, et al.
Life Sciences (2022) Vol. 312, pp. 121182-121182
Open Access | Times Cited: 8

Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p/Col1a1 axis
Binbin Li, Jiaming Zhou, Yuanyuan Luo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7

Noncoding RNA network crosstalk in organ fibrosis
Hui Ling, Xian-Chen Wang, Zhiyan Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111430-111430
Closed Access | Times Cited: 1

Circular RNAs in organ injury: recent development
Ryan Wong, Yiwen Zhang, Hailin Zhao, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top